No quarterly revenue total was found in CELCUITY INC.'s SEC filings.
Celcuity Inc. (CELC) files with the SEC under industry code 8071, Services-Medical Laboratories. Free cash flow was -$66.2 million. As of Sep 30, 2026 it held $642.7 million in cash and investments and $1.1 million in total debt.
Revenue
—
Net income
$-73.34M
-67.4% vs year-ago quarter
Operating cash flow
$-66.23M
-47.8% vs year-ago quarter
Free cash flow
$-66.24M
-47.5% vs year-ago quarter
EPS
$-1.33
-44.6% vs year-ago quarter
Dividend per share
None
Shares outstanding
49.13M
+6.2% vs year-ago quarter
Net cash
$641.60M
Q3 FY2026
Operating margin
—
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CELC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1603454
- Former names
- Celcuity LLC (until Sep 15, 2017)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$77.3M | -$66.1M | -$50.5M | -$49.2M | -$42.8M |
| Net income | -$73.3M | -$78.9M | -$52.8M | -$51.0M | -$43.8M |
| Diluted EPS | -$1.33 | -$1.44 | -$0.97 | -$0.97 | -$0.92 |
| Operating cash flow | -$66.2M | -$55.4M | -$55.1M | -$36.4M | -$44.8M |
| Free cash flow | -$66.2M | -$55.5M | -$55.3M | -$36.5M | -$44.9M |
| Total assets | $726.9M | $828.2M | $410.2M | $466.6M | $476.0M |
| Total liabilities | $800.9M | $841.0M | $356.6M | $366.0M | $359.0M |
| Stockholders' equity | -$74.0M | -$12.8M | $53.5M | $100.6M | $117.0M |
| Cash and investments | $642.7M | $754.0M | $387.1M | $441.5M | $455.0M |
| Total debt | $1.1M | $1.1M | $137.9M | $137.6M | $137.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 2, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
All 541 Celcuity Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.